Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 11251-11300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT07068763
Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer
PHASE2Not yet recruiting
52 participants
Started: Aug 8, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor0 locations
NCT07172516
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
PHASE3Recruiting
400 participants
Started: Aug 8, 2025 · Completed: Aug 31, 2028
4 conditions1 sponsor9 locations
NCT07031531
Effectiveness of an AI-Enabled Stratified Management System for Premature Coronary Artery Disease
NARecruiting
4,900 participants
Started: Aug 8, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor16 locations
NCT07130955
A Randomized Controlled Trial Evaluating the Efficacy and Safety of a Six-Channel Radiofrequency Ablation System Used in Renal Denervation for Treating Patients With Uncontrolled Hypertension and Chronic Kidney Disease
NAEnrolling by invitation
330 participants
Started: Aug 8, 2025 · Completed: Sep 30, 2030
2 conditions22 sponsors1 location
NCT07099001
Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay
NARecruiting
150 participants
Started: Aug 8, 2025 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT07170644
A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
PHASE2Recruiting
18 participants
Started: Aug 8, 2025 · Completed: Dec 31, 2030
2 conditions1 sponsor2 locations
NCT07191821
TSPO Modulation in AD
PHASE2Enrolling by invitation
51 participants
Started: Aug 8, 2025 · Completed: Jun 1, 2027
1 condition1 sponsor1 location
NCT06168058
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
NARecruiting
40 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2026
5 conditions4 sponsors3 locations
NCT06691243
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
PHASE2Recruiting
40 participants
Started: Aug 7, 2025 · Completed: Mar 31, 2027
2 conditions2 sponsors2 locations
NCT07133594
Validation of a Questionnaire in the French Language for the Patient Experience in Radiotherapy
NAActive, not recruiting
320 participants
Started: Aug 7, 2025 · Completed: Nov 30, 2026
2 conditions1 sponsor1 location
NCT06892093
Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients
NARecruiting
308 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT07098351
Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis
NARecruiting
93 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2026
4 conditions1 sponsor1 location
NCT07067567
A Study of AK146D1 for Injection in Advanced Solid Tumors
PHASE1Recruiting
200 participants
Started: Aug 7, 2025 · Completed: May 5, 2027
1 condition1 sponsor1 location
NCT06922630
WIN: a Feasibility Study of a Weight-Neutral Health Intervention
NAActive, not recruiting
56 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT07153159
A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Breastfeeding Women
PHASE1Recruiting
8 participants
Started: Aug 7, 2025 · Completed: Oct 12, 2026
1 condition1 sponsor1 location
NCT06692192
The RECAP2 Study: Midazolam and Psilocybin
PHASE1Recruiting
60 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT07162181
Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers
PHASE2Recruiting
13 participants
Started: Aug 7, 2025 · Completed: May 31, 2030
3 conditions1 sponsor6 locations
NCT06981325
Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients
PHASE2Recruiting
34 participants
Started: Aug 7, 2025 · Completed: Jul 31, 2029
2 conditions4 sponsors5 locations
NCT06963736
WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time
NARecruiting
30 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT07079865
Effect of 60-day Peripheral Nerve Stimulation (PNS) in Alleviating Pain and Improving Function After Acute Thoracolumbar Compression Fracture
N/ARecruiting
15 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors3 locations
NCT07010016
Neuromodulation in Substance Use Disorders
NAActive, not recruiting
20 participants
Started: Aug 7, 2025 · Completed: Jul 30, 2028
1 condition1 sponsor1 location
NCT07013565
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL
PHASE2Active, not recruiting
20 participants
Started: Aug 7, 2025 · Completed: Jul 1, 2030
1 condition11 sponsors1 location
NCT07023289
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
PHASE2Recruiting
140 participants
Started: Aug 7, 2025 · Completed: Nov 30, 2029
1 condition1 sponsor17 locations
NCT07091032
Building Connections
NARecruiting
3,600 participants
Started: Aug 7, 2025 · Completed: Dec 30, 2029
4 conditions1 sponsor1 location
NCT06792825
HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
PHASE2Recruiting
65 participants
Started: Aug 7, 2025 · Completed: Jul 8, 2031
2 conditions2 sponsors1 location
NCT06556121
Saddle Block With IT Morphine for Penile Inversion Vaginoplasty
NARecruiting
40 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06815471
CRF2 Agonist for the Treatment of Worsening Heart Failure
PHASE2Recruiting
300 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2026
1 condition2 sponsors10 locations
NCT06967324
GRACE - Graduated Response for Advanced COPD With Enhanced Support
NARecruiting
100 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor1 location
NCT07050433
Correlate Biomarkers for the SYNERGY- 201 Study
N/ARecruiting
48 participants
Started: Aug 7, 2025 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT06901310
A Feasibility Study in Combat Athletes With Mild Traumatic Brain Injury
NAEnrolling by invitation
10 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT06854159
Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy
PHASE2Recruiting
34 participants
Started: Aug 7, 2025 · Completed: Apr 30, 2029
4 conditions2 sponsors1 location
NCT07102836
COMPARISON OF ZINC AND PROBIOTICS ON NEONATES WITH INDIRECT HYPERBILIRUBINEMIA UNDERGOING PHOTOTHERAPY
PHASE2Recruiting
110 participants
Started: Aug 7, 2025 · Completed: May 7, 2026
2 conditions1 sponsor1 location
NCT07119866
The Role of Oxygen Reserve Index (ORi) in Apneic Ventilation
N/ANot yet recruiting
60 participants
Started: Aug 7, 2025 · Completed: Aug 30, 2025
4 conditions1 sponsor1 location
NCT07122245
Demographics of Lung Cancer in Females
N/ARecruiting
300 participants
Started: Aug 7, 2025 · Completed: Apr 7, 2026
1 condition1 sponsor1 location
NCT07094425
Intensive Care Unit-acquired Heart Failure in Critically Ill: the ICU-HF Study
N/ARecruiting
50 participants
Started: Aug 7, 2025 · Completed: Nov 1, 2026
2 conditions2 sponsors2 locations
NCT07124520
A Study of Tongue Strength and Endurance Using the Iowa Oral Performance Instrument (IOPI) Tongue Strength Trainer in People With Oral Tongue Cance
NARecruiting
60 participants
Started: Aug 7, 2025 · Completed: Aug 7, 2028
1 condition1 sponsor7 locations
NCT07114640
The Effect of Nighttime Mirabegron, Solifenacin, Tolterodine, or Oxybutynin on Nocturia, Sexual Function, Autonomic Function, and Lower Urinary Tract Blood Flow Perfusion in Women With Overactive Bladder Syndrome: Randomized Controlled Trial
PHASE3Not yet recruiting
220 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06925477
Direct vs. Conventional SLT in Open-Angle Glaucoma: A RCT
NAEnrolling by invitation
51 participants
Started: Aug 7, 2025 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06896916
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
PHASE1Recruiting
135 participants
Started: Aug 7, 2025 · Completed: Mar 31, 2036
1 condition1 sponsor14 locations
NCT07098338
A Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
PHASE2Recruiting
278 participants
Started: Aug 7, 2025 · Completed: Apr 6, 2029
1 condition2 sponsors57 locations
NCT06825403
Olfactory Training in Mild Cognitive Impairment
NARecruiting
30 participants
Started: Aug 7, 2025 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT06918119
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
NARecruiting
30 participants
Started: Aug 7, 2025 · Completed: Jul 31, 2030
2 conditions1 sponsor1 location
NCT07007793
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
PHASE3Recruiting
180 participants
Started: Aug 7, 2025 · Completed: Feb 18, 2028
1 condition1 sponsor88 locations
NCT07127562
Effect of a Simplified Mindfulness Intervention on Health-related Quality of Life in Patients Undergoing Hematopoietic Stem Cell Transplantation: A Prospective Single-Center Randomized Controlled Trial
NANot yet recruiting
148 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2027
1 condition1 sponsor0 locations
NCT07092592
Optical Coherence Tomography (OCT) Based Intraoral Scanner
N/ANot yet recruiting
70 participants
Started: Aug 7, 2025 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT06865339
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
PHASE2Recruiting
76 participants
Started: Aug 7, 2025 · Completed: Aug 31, 2027
2 conditions5 sponsors1 location
NCT06732401
Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer
PHASE3Recruiting
630 participants
Started: Aug 7, 2025 · Completed: Jun 30, 2028
4 conditions1 sponsor116 locations
NCT06923462
VoiceLove: An App-Based COMMunication Tool Designed to Address DeliriUm and Improve Family ENgagement and PatIent/Family SatisfaCtion in CriticAlly Ill PaTiEnts (COMMUNICATE)
NARecruiting
100 participants
Started: Aug 6, 2025 · Completed: Mar 15, 2028
2 conditions1 sponsor1 location
NCT07158918
ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Recruiting
65 participants
Started: Aug 6, 2025 · Completed: Dec 2, 2027
1 condition2 sponsors6 locations
NCT06712927
Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases
PHASE2Recruiting
60 participants
Started: Aug 6, 2025 · Completed: Feb 28, 2030
2 conditions1 sponsor1 location